Effects of Ca2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis

British Journal of Pharmacology

Volumn 123, Issue 5, 1998, Pages 805-814

  Okada, Motohiro ^a   Wada, Kazumaru ^a   Kiryu, Kazuhiro ^a   Kawata, Yuko ^a   Mizuno, Kazuhisa ^a   Kondo, Tuyoshi ^a   Tasaki, Hiroichi ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

agatoxin IVA; conotoxin GVIA; conotoxin MVIIC; 3,4 dihydroxyphenylalanine; Dopamine; Striatum

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DOPA; DOPAMINE; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIC; TYROSINE 3 MONOOXYGENASE; CALCIUM; POTASSIUM;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DIFFUSION; DRUG EFFECT; EVOKED RESPONSE; EXTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CORPUS STRIATUM; DIFFUSION; DIHYDROXYPHENYLALANINE; DOPAMINE; EVOKED POTENTIALS; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; POTASSIUM; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

EID: 0031594722     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701675     Document Type: Article

References (38)

1. AUGUSTINE, G.J., CHARLTON, M.P. & SMITH, S.J. (1987). Calcium action in synaptic transmitter release. Ann. Rev. Neurosci., 10, 633-693.
2. BASMA, A.N., MORRIS, E.J., NICKLAS, W.J. & GELLER, H.M. (1995). L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem., 64, 825-832.
3. 2+ channels in mammalian central neurons. Trends Neurosci., 18, 89-98.
4. GOETZ, C.G., TANNER, C.M., GLANTZ, R. & KLAWANS, H.L. (1983). Pergolide in Parkinson's disease. Arch. Neurol., 40, 785-787.
5. HARVEY, J., WEDLEY, S., FINDLAY, J.D., SIDELL, M.R. & PULLAR, I.A. (1996). ω-Agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine. dopamine, γ-aminobutylic acid and glutamate from rat brain slices. Neuropharmacology, 35, 385-392.
6. 2+ channels. Neuron, 9, 69-77.
7. KATO, T., OTSU, Y., FURUNE, Y. & YAMAMOTO, T. (1992). Different effects of L-. N- and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rats. Neurochem. Int., 21, 99-107.
8. + -evoked [3H]norepinephrine release from hippocampal brain slices and synaptosomal calcium influx. Biochem. Pharmacol., 45, 165-171.
9. KIMURA, M., YAMASHITA, Y., HANADA, T., KAGAYA, T., KUWADA, M., WATANABE, T., KATAYAMA, K. & NISHIZAWA, Y. (1995). Involvement of P-type calcium channels in high potassium-elicited release of neurotransmitters from rat brain slices. Neuroscience, 66, 609-615.
10. MISU, Y. & GOSHIMA, Y. (1993). Is L-dopa an endogenous neurotransmitter? Trends Pharmacol. Sci., 14, 119-123.
11. MISU, Y., UEDA, H. & GOSHIMA, Y. (1995a). Neurotransmitter-like actions of L-DOPA. Adv. Pharmacol., 32, 427-459.
12. MISU, Y., YUE, J.L. & GOSHIMA, Y. (1995b). L-DOPA systems for blood pressure regulation in the lower brainstem. Neurosci. Res., 23, 147-158.
13. MULKEY, R.M. & ZUCKER, R.S. (1991). Action potentials must admit calcium to evoke transmitter release. Nature. 350, 153-155.
14. NESTLER, E.J. & GREENGARD, P. (1994). Protein phosphorylation and the regulation of neuronal function. In Basic Neurochemistry, fifty edition. ed. Siegel, G.J., Agranoff, B.W., Albers, R.W. & Molinoff, P.B. New York: Raven Press, pp. 449-490.
15. 2+ dependent dopamine release. Epilepsy Res., 13, 113-119.
16. OKADA, M., KANEKO, S., HIRANO, T., MIZUNO, K., KONDO, T., OTANI, K. & FUKISHIMA, Y. (1995). Effects of zonisamide on dopaminergic system. Epilepsy Res., 22, 193-205.
17. OKADA, M., MIZUNO, K., OKUYAMA, M. & KANEKO, S. (1996a). Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum. Psychiatry Clin. Neurosci., 50, 147-156.
18. 2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett., 212, 53-56.
19. OKADA, M., KIRYU, K., KAWATA, Y., MIZUNO, K., WADA, K., TASAKI, H. & KANEKO, S. (1997a). Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol., 32, 181-188.
20. OKADA, M., HIRANO, T., MIZUNO, K,. CHIBA, T., KAWATA, Y., KIRYU, K., WADA, K., TASAKI, H. & KANEKO, S. (1997b). Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res., 28, 143-153.
21. OKADA, M., KAWATA, Y., KIRYU, K., MIZUNO, K., WADA, K., INOMATA, H. & KANEKO, S. (1997c). Effects of non-toxic and toxic concentrations of phenytoin on monoamine levels in rat brain. Epilepsy Res., 28, 155-163.
22. OKADA, M., KAWATA, Y., KIRYU, K., MIZUNO, K., WADA, K., TASAKI, H. & KANEKO, S. (1997d). Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J. Neurochem., 69, 2581-2588.
23. OLIVERA, B.M., MILJANICH, G.P., RAMACHANDRAN, J, & ADAMS, M.E. (1994). Calcium channel deversity and neurotransmitter release: the omega-conotoxin and omega-agatoxin. Annu. Rev. Biochem.,. 63, 823-867.
24. OTANI, K,. MIHARA, K., KONDO, T., OKADA, M., KANEKO, S. & FUKUSHIMA, Y. (1991a). Treatment of neuroleptic malignant syndrome with levodopa. Human Psychopharmacol., 7, 217-221.
25. OTANI, K., MIHARA, K., OKADA, M., KANEKO, S. & FUKUSHIMA, Y. (1991b). Crossover reaction between haloperidol and amoxapine for NMS. Br. J. Psychiatry, 159, 889.
26. PANI, L., KUZMIN, A., DIANA, M., DEMONTIS, G., GESSA, G.L. & ROSSETTI, Z.L. (1990), Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur. J. Pharmacol., 190, 217-221.
27. 2+ channel currents in rat cerebellar granule neurones. J. Neurosci., 15, 2995-3012.
28. SMITH, S.J. & AUGUSTINE, G.I. (1988) Calcium ions, active zones and synaptic transmitter release. Trends Neurosci., 11, 485-464.
29. TAKAHASHI, T. & MOMIYAMA, A. (1993). Different types of calcium channels mediate central synaptic transmission. Nature, 336, 156-158.
30. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. U.S.A., 90, 9518-9522.
31. WESTERINK, B.H.C., HOFSTEEDE, H.M., DAMSMA, G. & DEVRIES, J.B. (1988). The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 373-378.
32. WESTERINK, B.H.C., HOFSTEEDE, R.M., TUNTLER, J. & DE VRIES, J. B. (1989). Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J. Neurochem., 52, 722-729.
33. WESTERINK, B.H.C., DE VRIES, J.B. & DURAN, R. (1990). Use of microdialysis for tyrosine hydroxylase activity in the brain of conscious rats. J. Neurochem., 54, 381-387.
34. 2+ channels in supporting hippocampal synaptic transmission. Science. 264, 107-111.
35. WILLIAMS, M.E., BRUST, P.F., FELDMAN, D.H., SARASWATHI, P., SIMERSON, S., MAROUFI, A., MCCUE, A.F., VELICELEBI, G., ELLIS, S.B. & HARPOLD, M.M. (1992). Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel. Science. 257, 389-395.
36. YUE, J.L., GOSHIMA, Y. & MISU, Y. (1993). Transmitter-like L-3.4-dihydroxyphenylalanine tonically functions to mediate vasodepressor control in the caudal ventrolateral medulla of rats. Neurosci. Lett., 159, 103-106.
37. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology, 32, 1075-1088.
38. ZHANG, Y.X., YAMASHITA, H., OHSHITA, T., SAWAMOTO, N. & NAKAMURA, S. (1995). ATP increases extracellular dopamine level through stimulation of P2Y purinoceptors in the rat striatum. Brain Res., 691, 205-212.